INS and type 2 diabetes mellitus: The link between EDCs, type II diabetes and MetS is attested by the adverse effects of EDCs on insulin secretion by the pancreatic β‐cells and by their peripheral actions, notably on muscle cells or adipocytes which are implicated in the development of insulin resistance.